Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-29

Clinical Trial Update: A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating peginterferon for herpes zoster has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginterferon (Pegylated interferon)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED